Drug profile

The FDA adverse-event record for Unspecified Bordetella Vaccine

42 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Unspecified Bordetella Vaccine. See the species affected, top reactions, and outcomes below.

42
adverse-event reports
11.9%
death-coded share
Dog
most-reported species
10
Lethargy (see also Central nervous system depression in Neurological) - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
42
Total Reports
5
Deaths Reported
11.9%
Death Rate

Active Ingredients

Unspecified Bordetella Vaccine

Administration Routes

UnknownOralNasalSubcutaneous

Species Affected

Dog 42

Most Affected Breeds

Shepherd Dog - German 4
Shih Tzu 3
Pit Bull 2
Dog (unknown) 2
Havanese 2
Beagle 2
Chihuahua 2
Poodle - Standard 2
Terrier - Yorkshire 2
Retriever - Labrador 2

Most Reported Reactions

Lethargy (see also Central nervous system depression in Neurological) 10
Diarrhoea 9
Vomiting 9
Emesis (multiple) 6
Not himself/herself 5
Lethargy (see also Central nervous system depression in 'Neurological') 4
Not eating 4
Death by euthanasia 4
Anorexia 4
Itching 4
Disorientation 4
Shaking 3

Outcome Breakdown

Outcome Unknown
14 (33.3%)
Ongoing
14 (33.3%)
Recovered/Normal
9 (21.4%)
Euthanized
4 (9.5%)
Died
1 (2.4%)

Unspecified Bordetella Vaccine Adverse Event Insights

42 reports name Unspecified Bordetella Vaccine; 5 recorded a death outcome (11.9% of reported events, not a population-level mortality rate). Active ingredient: Unspecified Bordetella Vaccine. Administration routes: Unknown, Oral, Nasal, Subcutaneous.

By species: Dog (42 reports). By breed: Shepherd Dog - German (4), Shih Tzu (3), Pit Bull (2).

Leading clinical signs: Lethargy (see also Central nervous system depression in Neurological) (10), Diarrhoea (9), Vomiting (9), Emesis (multiple) (6). Outcome, 42 coded reports: Outcome Unknown leads at 33.3%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.